Top compounds associated with response to CALR3


Feature Type Standardized
Nominal ANOVA
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.036 0.3
mRNA nintedanib CTRPv2 pan-cancer AAC -0.037 0.3
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA GW843682X CTRPv2 pan-cancer AAC 0.034 0.3
mRNA MI-1 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA CI-976 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.036 0.3
mRNA compound 1B CTRPv2 pan-cancer AAC -0.038 0.3
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
Download CSV